CYCN · CIK 0001755237 · operating
Cyclerion Therapeutics, Inc. (CYCN) is a pharmaceutical preparations company incorporated in MA, listed on the Nasdaq. With a market capitalization of $5 million, Cyclerion Therapeutics, Inc. is a micro-cap company. The stock currently trades at $1.34, down 1.35% today, with a 52-week range of $1.03–$3.79.
Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.
| Fiscal Year | EPS Diluted | EPS Basic | YoY | |
|---|---|---|---|---|
| 2024 | $-1.21 | $-1.21 | +46.2% | |
| 2023 | $-2.25 | $-2.25 | -122.8% | |
| 2022 | $-1.01 | $-1.01 | — | |
| 2021 | — | — | — | |
| 2020 | — | — | — | |
| 2019 | — | — | — |
| Report Date | Filed | Accession Number | |
|---|---|---|---|
| 2024-12-31 | 2025-03-04 | 0000950170-25-032037 | SEC ↗ |
| 2023-12-31 | 2024-03-05 | 0000950170-24-025935 | SEC ↗ |
| 2022-12-31 | 2023-03-22 | 0000950170-23-009223 | SEC ↗ |
| 2021-12-31 | 2022-02-24 | 0000950170-22-001958 | SEC ↗ |
| 2020-12-31 | 2021-02-25 | 0001564590-21-008434 | SEC ↗ |
| 2019-12-31 | 2020-03-12 | 0001104659-20-032554 | SEC ↗ |